STOCK TITAN

Plexus (PLXS) insider schedules 2,321-share Rule 144 sale after recent stock disposals

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Plexus Corp. insider plans additional stock sale under Rule 144. A holder intends to sell 2,321 shares of Plexus common stock through Morgan Stanley Smith Barney LLC, with an aggregate market value of $466,806.25 and 26,786,466 shares outstanding as of the notice.

The shares to be sold were acquired as performance shares from the issuer on 02/11/2025. The filing also lists prior sales by Patrick Jermain over the past three months, including 3,587 and 4,841 common shares sold on 02/04/2026 and 02/03/2026, respectively, with gross proceeds of $732,070.83 and $987,612.41.

Positive

  • None.

Negative

  • None.

Insights

Rule 144 filing shows ongoing insider share sales of limited size.

The notice indicates an intended sale of 2,321 Plexus common shares with a market value of $466,806.25, relative to 26,786,466 shares outstanding. This points to a relatively small transaction in the context of the company’s equity base.

The seller, identified as Patrick Jermain in the recent three‑month history, previously sold blocks of 3,587 and 4,841 shares on 02/04/2026 and 02/03/2026, generating gross proceeds of $732,070.83 and $987,612.41. Actual market impact depends on execution but the volumes disclosed here are modest compared with total shares outstanding.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the Form 144 filing for PLXS disclose?

The Form 144 for PLXS discloses an intended sale of 2,321 Plexus common shares with an aggregate market value of $466,806.25, using Morgan Stanley Smith Barney LLC as broker, under Rule 144 resale provisions for restricted or control securities.

How many Plexus (PLXS) shares are planned to be sold under this Form 144?

The filing shows an intent to sell 2,321 shares of Plexus common stock. These shares were acquired as performance shares from the issuer on February 11, 2025, and are to be sold on NASDAQ through Morgan Stanley Smith Barney LLC.

What is the aggregate market value of the PLXS shares in this Form 144?

The intended 2,321-share sale of Plexus common stock has an aggregate market value of $466,806.25. This figure reflects the market value used in the notice for the planned Rule 144 transaction on NASDAQ.

How many Plexus (PLXS) shares are outstanding in this Form 144 notice?

The notice states that 26,786,466 shares of Plexus common stock are outstanding. This provides context for the relative size of the planned 2,321-share sale under Rule 144 compared with the company’s total share count.

What recent PLXS stock sales by the filer are disclosed?

The filing lists prior sales by Patrick Jermain of 3,587 shares on February 4, 2026 for $732,070.83 and 4,841 shares on February 3, 2026 for $987,612.41, all in Plexus common stock.

How were the PLXS shares in the current Form 144 acquired?

The 2,321 Plexus shares in this notice were acquired as performance shares from the issuer on February 11, 2025. The form identifies the acquisition type and confirms the issuer as the source of the awarded shares.